Intratumoral treatment with two doses of IL-15 complexes alone generated partial responses in 42% of mice (five out of twelve), in which these mice showed significantly delayed tumor progression compared to vehicle control (Figure 1E), while promoting tumor clearance in 58% of mice (seven out of twelve) (Figure 1F and Supplemental Figure S1H). The gene discussed is IL15; the disease is neoplasm.